Dr. Reddy’s Laboratories launches NIVORZ in India
Dr. Reddy’s Laboratories announced the launch of NIVORZ (Nivolumab Biosimilar) in India. NIVORZ is a biosimilar to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
Dr. Reddy’s launches initiative to train India’s obesity care workforce
More than 5,000 healthcare support professionals to be trained to strengthen obesity prevention, education and long-term…
Aurigene enters into long-term manufacturing, supply partnership with a leading global pharma…
Aurigene Pharmaceutical Services (“Aurigene”), a wholly owned subsidiary of Dr. Reddy's Laboratories announced a strategic,…
Aurigene enters long-term manufacturing and supply partnership with a global pharma company
The counterparty's name has not been disclosed in view of confidentiality obligations under the agreement
Dr Reddy’s whitepaper outlines roadmap for strengthening India’s translational research ecosystem
Report identifies priorities to improve translational research through collaboration, funding, regulation and clinical data…
Dr Reddy’s submits Abatacept Biosimilar BLA to USFDA for review
351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid arthritis, psoriatic arthritis and pJIA
Dr Reddy’s Laboratories acquires Progynova and Cyclo-Progynova trademarks from Mercury Pharma for…
Acquisition strengthens gynaecology portfolio and marks entry into hormone replacement therapy segment
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…
Senores Pharmaceuticals launches Deferiprone Tablets USP in the U.S.
The product will be marketed by Dr Reddy’s Laboratories
AI compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…